Rivaroxaban
Catalog No.: BA5U41
CAS.RN：366789-02-8
Molecular Formula: C19H18ClN3O5S
Molecular Weight: 435.88 g/mol
Purity: NLT 98%
Intermediates of Rivaroxaban
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA5U41 | Rivaroxaban API | 366789-02-8 |
| BK3K93 | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| BK1FM3 | 3-Morpholinone, 4-phenyl- | 29518-11-4 |
| BK98L6 | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| BK00VZ | 5-Chlorothiophene-2-carbonyl chloride | 42518-98-9 |
| BK4V1V | 3-Morpholinone, 4-[4-[(5s)-5-(aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]- | 446292-10-0 |
| BK40MH | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
| BK2HX3 | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 |
| BK9H9M | 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | 446292-08-6 |
| BK5P8T | (R)-2-(2-hydroxy-3-(4-(3-oxomorpholino)phenylamino)propyl)isoindoline-1,3-dione | 446292-07-5 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
